Cooley M&A

APRIL 27, 2021

Cooley, DFIN, PwC, Nasdaq and The Blueshirt Group took part in a two-part webinar series Behind the Scenes of the 2021 IPO & SPAC Boom on May 4 & 11, 2021. Session One – Tuesday, May 4, 2021, 9:00 – 10:30 am PT. Session Two – Tuesday, May 11, 2021, 9:00 – 10:30 am PT.

IPO 52

IPO Capital Raising Capital Market Mergers 52

The TRADE

FEBRUARY 29, 2024

The London Stock Exchange (LSEG) saw overall growth across its key businesses in 2023, with considerable improvement across data and analytics, capital markets, and in particular, post-trade. year-on-year increase, while capital markets saw a 6.1% In capital markets, the 6.1%

Trading 110

Trading Acquisitions Capital Market Book-building 110

Cooley M&A

SEPTEMBER 30, 2021

Judges selected finalists for the Transatlantic Corporate Team of the Year award based on standout corporate transactions in one of the following fields: IPOs, public M&A, private equity or corporate reorganizations.

Corporation 40

Corporation Private Equity IPO M&A 40

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Razorpay

AUGUST 9, 2023

Underwriting Services Merchant banks also provide underwriting services for initial public offerings (IPOs), private placements, follow-on public offerings (FPOs) and rights issues. Axis Capital: Leading merchant bank with a focus on debt capital markets, providing services such as debt issuance, restructuring, and advisory.

Bank 52

Bank Banking Business Underwriting 52

Cooley M&A

JANUARY 20, 2022

Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 19 treatments from Pfizer, Merck and potentially others hitting the market soon , we expect Big Pharma to continue to parlay this cash flow into growth in other areas of strategic focus.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 22, 2021

2020 was also a blockbuster year for special purpose acquisition company (SPAC) activity, as 247 SPAC IPOs raised more than $75 billion (a 525% increase compared to the amount raised by SPAC IPOs in 2019) [3]. Creative deal terms and financing arrangements were also attractive aspects of SPAC deals as compared to their IPO cousin.

M&A 40

M&A IPO Mergers and Acquisitions Business 40